Pharmafile Logo
Pharmafocus logo
Advanced Search

injectables

Showing 8 posts of 8 posts found.

Baxter expands US portfolio with new injectables

April 12, 2024
Medical Communications Pharmacy, baxter, injectables, product launch

Baxter International has announced the continued expansion of its pharmaceuticals portfolio with the launch of five new injectable products in …

News

ViiV Healthcare shares interim data from phase 3 trial for injectable HIV treatment

February 21, 2024
Research and Development Cabenuva, HIV, HIV/AIDS, ViiV Healthcare, clinical trial, injectables

ViiV Healthcare has announced results from an interim analysis of the phase 3 LATITUDE trial, which assessed Cabenuva (cabotegravir and …

News
injection-519388_960_720

Injectable drug market to grow to $625 billion worldwide by 2021

March 23, 2017
Sales and Marketing injectable drugs, injectables

New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …

News
Hospira logo

Pfizer may sell off Hospira unit for $2 billion

January 14, 2016
Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps

Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …

News

Pfizer to pay $360m for InnoPharma

July 18, 2014
Sales and Marketing Pfizer, injectables, innopharma

Pfizer is to pay as much as $360 million for private pharma development company InnoPharma in a financial arrangement comprising …

News

Mitsubishi Tanabe recalls two million injectables

January 28, 2011
Manufacturing and Production Mitsubishi, injectables, recall

Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …

News
Pfizer headquarters

Pfizer pays $63m for generics portfolio

January 5, 2011
Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables

Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …

News
Chris Begley

Hospira buys Orchid generic injectables business for $400m

December 18, 2009
Manufacturing and Production Hospira, India, Orchid, injectables

Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024